Demonstration of an AI-powered tool during a live surgery at The Neuro
A surgical device powered by artificial intelligence (AI) was demonstrated live for the first time at The Neuro (Montreal Neurological Institute-Hospital) in a historic step forward for the field of precision neurosurgery. SENTRY™, an innovative technology developed by Montreal-based Reveal and its university partners, can differentiate cancerous tissue from healthy tissue in real time, offering tangible hope to patients for better outcomes.
Quebec Health Minister Christian Dubé was welcomed at The Neuro today by Dr. Lucie Opatrny, President and Executive Director of the McGill University Health Centre (MUHC), to view this procedure that will enable safer and more effective precision surgeries. They also had the chance to meet and speak with a patient who had taken part in a previous study to gather data for the system.
Concrete impact for patients
The surgery performed by The Neuro’s Dr. Kevin Petrecca marks a major medical step forward. The result of a more than ten-year research collaboration with Frédéric Leblond, a professor at Polytechnique Montreal, this device heralds a new era in AI-assisted precision surgery. This real patient demonstration illustrates the device’s potential to transform our treatment of brain tumours, one of medicine’s most complex dilemmas.